Display options
Share it on
Full text links
View full text

J Cummings, T Morstorf, G Lee - Alzheimer's & Dementia: Translational …, 2016 - Elsevier

Alzheimer's drug-development pipeline: 2016.

pipeline programs

Cummings

GSID: 1SBc_9oI--QJ

Excerpt

… This analysis of clinicaltrials.gov reveals that there are relatively few agents in AD drug-development programs. The high failure rate in AD drug development and the small number of drugs being assessed suggest that the emergence of a repertoire of AD agents that could be …

Similar articles

Cited by